Heranba, a leading agrochemical company in India and one of India’s leading Synthetic Pyrethroids and its intermediates manufacturer in India, has registered flat growth of 1.22% in Q2 FY22 to reach Rs. 353.43 crore as compared to Rs. 349.18 crore in Q2 FY21.

Profit After Tax stood at Rs. 45.62 crore showing a growth of 20.9% Y-o-Y. EBITDA (including other income) was at Rs. 66.35 crore in Q2 FY22 as compared to Rs. 565.78 million in Q2 FY21, a growth of 17.27% Y-o-Y and de-growth of 3.97% Q-o-Q.

Raghuram K. Shetty, Managing Director, Heranba Industries Limited said, “I am pleased to report that we have maintained our growth momentum in the first half of FY22 by reporting a strong set of numbers. We saw an increase of 14% in our revenues and an increase of 40% in our PAT in H1 FY22. Our continued growth trajectory in yet another half year and quarter shows the strong and resilient DNA that we are built on. We are dedicated to accelerating revenue growth and productivity efforts in order to achieve significant margin expansion, and we continue to view FY22 as a crucial acceleration point in Heranba's trajectory.”

The company's mission is to improve crop productivity and public health. It is committed to the wellness of world citizens. Heranba manufactures Synthetic Pyrethroids and its intermediates in India. It has 3(three) manufacturing facilities across India with employee strength of more than 650. It has a wide network of businesses in India as well as across the globe. Heranba has expertise on all the key chemical reactions on a commercial scale.